High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with >= 4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study
Author(s):
Steenbruggen, T.G.; Steggink, L.C.; Seynaeve, C.M.; Hoeven, J.J.M. van der; Hooning, M.J.; Jager, A.; Konings, I.R.; Kroep, J.R.; Smit, W.M.; Tjan-Heijnen, V.C.G.; Wall, E. van der; Bins, A.D.; Linn, S.C.; Schaapveld, M.; Leeuwen, F.E. van; Schroder, C.P.; Tinteren, H. van; Vries, E.G.E. de; Sonke, G.S.; Gietema, J.A.
